Proteome Sciences (LON:PRM) Stock Price Down 13.8% – Here’s What Happened

Proteome Sciences plc (LON:PRM)’s share price dropped 13.8% during mid-day trading on Thursday . The company traded as low as GBX 2.89 ($0.04) and last traded at GBX 3.06 ($0.04). Approximately 1,115,348 shares traded hands during trading, an increase of 410% from the average daily volume of 218,703 shares. The stock had previously closed at GBX 3.55 ($0.05).

Proteome Sciences Stock Performance

The company has a market cap of £8.54 million, a price-to-earnings ratio of -2.09 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The stock’s fifty day simple moving average is GBX 4.08 and its 200 day simple moving average is GBX 3.46.

Proteome Sciences (LON:PRM) last posted its earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.01)) EPS for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.